CTLA4 gene haplotypes cannot protect from IDDM in the presence of high- risk HLA DQ8 or DQ2 alleles in German families

Diabetes

Volumn 47, Issue 7, 1998, Pages 1158-1160

  Donner, Horst ^a   Seidl, Christian ^c   Braun, Jens ^a   Siegmund, Thorsten ^a   Herwig, Jürgen ^b   Seifried, Erhard ^c   Usadel, Klaus Henning ^a   Badenhoop, Klaus ^a,b  

^a Center of Internal Medicine   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Inst Transfus Med I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROTECTION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; GERMANY; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; IMMUNOCONJUGATES;

EID: 0031750760     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.7.1158     Document Type: Article

References (25)

1. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
2. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
3. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH: Susceptibility and resistance alleles of human leukocyte antigene (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112-2117, 1995
4. Altman DM, Sansom D, Marsh SGE: What is the basis for HLA-DQ associations with autoimmune diseases? Immunol Today 12:267-270, 1991
5. Todd JA, Bell JI, McDevitt HO: HLA-DQb gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Hum Mol Genet 329:599-604, 1987
6. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272:1811-1813, 1996
7. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA, Belgian Diabetes Registry: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:1075-1080, 1996
8. Marron MP, Raffel LJ, Garchon H-J, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng W-P, Park Y, Zhang Z-X, Goldstein DR, Tao Y-W, Beaurain G, Bach J-F, Huang H-S, Luo D-F, Zeidler A, Rotter JI, Yang MCK, Mod- ilevsky T, Maclaren NK, She J-X: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-1282, 1997
9. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K: CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146, 1997
10. Dariavach P, Mattei M-G, Golstein P, Lefranc M-P: Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol 18:1901-1905, 1988
11. Harper K, Balznno C, Rouvier E, Mattei M-G, Luciani M-F, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147:1037-1044, 1991
12. Leung HT, Linsley PS: The CD28 costimulatory pathway. Ther Immunol 1:217-228, 1994
13. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M. Restivo VA Jr, Ke X, Gray GS, Nadler LM: CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 92:811-815, 1995
14. Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, Reiner SL, Thompson CB: Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157:4762-4770, 1996
15. Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS: Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem 271:26762-26771, 1996
16. Reiser H, Stadecker MJ: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 335:1369-1377, 1996
17. Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, Wang Y, Walunas T, Bluestone J, Listman J, Finn PW: Regulation of CTLA-4 expression during T cell activation. J Immunol 156:4154-4159, 1996
18. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA: CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184:783-788, 1996
19. Tivol EA, Schweitzer AN, Sharpe AH: Costimulation and autoimmunity. Curr Opin Immunol 8:822-830, 1996
20. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism at the human CTLA-4 gene. Nucleic Acids Res 19:4018, 1991
21. Deichman K, Heinzmann A, Brüggenolte E, Forster J, Kurhr J: An Mse I RFLP in the human CTLA4 promoter. Biochem Biophys Res Commun 225:817-818, 1996
22. Klein J. The population. In Natural History of the Major Histocompatibility Complex. New York, Wiley, 1986, p. 609-658
23. Bennett ST, Wilson AJ, Esposito L, Bouzekri N, Undlien DE, Cucca F, Nistico L, Buzzetti R, Bosi E, Pociot F, Nerup J, Cambon-Thomsen A, Pugliese A, Shield JPH, McKinney PA, Bain SC, Polychronakos C, Todd JA, the IMDIAB Group: Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. Nat Genet 17:350-352, 1997
24. Leung HT, Bradshaw J, Cleaveland JS, Linsley PS: Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J Biol Chem 270:25107-25114, 1995
25. Marengére LEM, Waterhouse P, Duncan GS, Mittrücker H-W, Feng G-S, Mak TW: Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1170-1173, 1996